IRIS
CAMPAGNA, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.517
AS - Asia 2.408
EU - Europa 2.087
SA - Sud America 372
AF - Africa 146
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.403
SG - Singapore 841
IT - Italia 647
CN - Cina 492
VN - Vietnam 453
HK - Hong Kong 315
RU - Federazione Russa 308
BR - Brasile 291
FI - Finlandia 168
FR - Francia 149
DE - Germania 146
IE - Irlanda 143
SE - Svezia 110
GB - Regno Unito 88
UA - Ucraina 84
CI - Costa d'Avorio 76
NL - Olanda 76
IN - India 61
AT - Austria 57
CA - Canada 49
BD - Bangladesh 39
TR - Turchia 35
MX - Messico 34
AR - Argentina 33
ZA - Sudafrica 28
JP - Giappone 23
KR - Corea 22
DK - Danimarca 20
AU - Australia 19
ID - Indonesia 19
MA - Marocco 19
PL - Polonia 19
ES - Italia 17
PH - Filippine 16
IQ - Iraq 14
RO - Romania 14
CL - Cile 12
UZ - Uzbekistan 10
PK - Pakistan 9
TH - Thailandia 9
VE - Venezuela 9
CR - Costa Rica 8
BE - Belgio 7
EC - Ecuador 7
LT - Lituania 7
SA - Arabia Saudita 7
TW - Taiwan 7
CO - Colombia 6
EG - Egitto 6
KE - Kenya 6
PY - Paraguay 6
HN - Honduras 5
JM - Giamaica 5
JO - Giordania 5
CZ - Repubblica Ceca 4
HR - Croazia 4
IL - Israele 4
IR - Iran 4
LB - Libano 4
MY - Malesia 4
PE - Perù 4
SM - San Marino 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
PT - Portogallo 3
AZ - Azerbaigian 2
BO - Bolivia 2
CY - Cipro 2
ET - Etiopia 2
HU - Ungheria 2
KW - Kuwait 2
LV - Lettonia 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BW - Botswana 1
CH - Svizzera 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LC - Santa Lucia 1
ML - Mali 1
NP - Nepal 1
NR - Nauru 1
NZ - Nuova Zelanda 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 9.549
Salva come PNG Salva come JPEG
Città #
Dallas 736
Ashburn 721
Singapore 516
Hong Kong 302
San Jose 280
Chandler 276
Council Bluffs 242
Des Moines 146
Dublin 143
Ho Chi Minh City 140
Boardman 136
Helsinki 129
Beijing 106
Fairfield 102
Los Angeles 101
The Dalles 96
Hanoi 93
New York 92
Ancona 91
Jacksonville 87
Abidjan 76
Lauterbourg 68
Milan 63
Seattle 60
Munich 59
Wilmington 53
Moscow 51
Houston 49
Turin 49
Hefei 39
Woodbridge 38
Vienna 37
Lawrence 35
Orem 35
Princeton 35
Cambridge 34
Da Nang 33
Centro 32
Recanati 31
Turku 31
Chicago 29
Ann Arbor 28
Buffalo 28
Santa Clara 28
Shanghai 26
Amsterdam 25
Rome 25
São Paulo 25
Tolentino 25
Nuremberg 24
Washington 24
San Mateo 23
Haiphong 21
London 20
San Diego 20
Chennai 19
Redmond 18
Aversa 16
Montreal 15
Pavia 15
Brooklyn 14
Johannesburg 14
Stockholm 14
Tokyo 14
Atlanta 13
Istanbul 13
Wuhan 13
Brasov 12
Denver 12
Poplar 12
Curitiba 11
Frankfurt am Main 11
Guangzhou 11
Manchester 11
Mexico City 11
Naples 11
Warsaw 11
Boston 10
Hangzhou 10
Iesi 10
Marche 10
Ankara 9
Hải Dương 9
Pune 9
Rieti 9
Salt Lake City 9
San Francisco 9
Tashkent 9
New Delhi 8
Paris 8
Baghdad 7
Belo Horizonte 7
Boydton 7
Brussels 7
Casablanca 7
Jakarta 7
Mumbai 7
Phoenix 7
Piscataway 7
Pittsburgh 7
Totale 6.294
Salva come PNG Salva come JPEG
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 327
Nicotinamide N-Methyltransferase Inhibition in Endothelium: Effect on Cell Viability and Respiration 215
Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression 215
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 203
Paraoxonase-2 in osteosarcoma: potential for the development of a targeted anticancer therapy 198
Clinical performance and utility of a NNMT-based urine test for bladder cancer 181
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 177
C. spinosa L. subsp. rupestris Phytochemical Profile and Effect on Oxidative Stress in Normal and Cancer Cells 176
Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation 173
Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines 172
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 167
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential 165
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 165
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 160
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 153
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 152
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 150
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 146
Nicotinamide N-methyltransferase in endothelium protects against oxidant stress-induced endothelial injury 145
FTIRM analyses as a tool to explore cisplatin sensitivity of oral squamous cell carcinoma cell lines after PON2 knockdown 143
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 139
Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes 137
Bardoxolone Methyl Displays Detrimental Effects on Endothelial Bioenergetics, Suppresses Endothelial ET-1 Release, and Increases Endothelial Permeability in Human Microvascular Endothelium 137
Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation 136
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 136
Enhancing cisplatin efficacy in triple-negative breast cancer through pon2 silencing: insights from FTIRM analysis 134
Treatment of osteosarcoma and Merkel cell carcinoma cell lines with inhibitors of nicotinamide N-methyltransferase: potential for the development of targeted therapeutic strategy 132
Paraoxonase-2 expression in oral squamous cell carcinoma 129
Cancer stem cells from human tumor cell lines: molecular and phenotypic features 128
Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells 127
Molecular analysis of endometrial inflammation in preterm birth 127
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 126
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 126
Actin-spectrin scaffold supports open fenestrae in liver sinusoidal endothelial cells 124
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 120
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 120
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 118
Catecholamine O-Methyltransferase as a Promising Diagnostic and Therapeutic Target in Oral Squamous Cell Carcinoma 118
Molecular and phenotypic characterization of cancer stem cells from human tumor cell lines 117
Catechol-o-methyltransferase, a promising diagnostic marker for non-invasive detection of human urothelial carcinoma 116
Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity 116
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 115
PON2 silencing to evaluate the effectiveness of Cisplatin treatment in OSCC cells by FTIRM analyses 115
Macrocyclic peptides as allosteric inhibitors of nicotinamide N-methyltransferase (NNMT) 114
Potent Inhibition of Nicotinamide N-Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics 114
In Vitro Study of the Proliferation of MG63 Cells Cultured on Five Different Titanium Surfaces 113
Overexpression of Nicotinamide N-Methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation 113
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 112
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms 111
Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review 109
Nicotinamide N-methyltransferase gene silencing in endothelial cell lines: molecular and phenotypic characterization 108
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 108
Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside 108
Characterization of cancer stem cells from larynx and bladder carcinoma cell lines 107
NAD+ Homeostasis and NAD+-Consuming Enzymes: Implications for Vascular Health 106
The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update 103
Nicotinamide N-methyltransferase inhibition in endothelial cell lines: effect on the cellular phenotype, cell viability and bioenergetic balance 101
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance 98
Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches 97
The Multifaceted Role of the Polyphenol Curcumin: A Focus on Type 2 Diabetes Mellitus 97
Urinary Cell-Free DNA as a potential diagnostic biomarker for bladder cancer in older adults 95
Effect of nicotinamide N-methyltransferase gene silencing on endothelial bioenergetics. 95
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 93
Role of paraoxonase-2 in triple-negative breast cancer: effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 91
Nicotinamide N-methyltransferase inhibition in endothelium: effect on the cellular phenotype, viability and bio-energetics 89
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma 87
The Role of Xenobiotic Caffeine on Cardiovascular Health: Promises and Challenges 86
Involvment of the enzyme nicotinamide N-methyltransferase in proliferation, invasive capacity and chemosensitivity of human osteosarcoma. 84
Novel Ti6Al4V Surface Treatment for Subperiosteal Dental Implants: Evaluation of Osteoblast-like Cell Proliferation and Osteogenic Response 84
Exploring the role of paraoxonase-2 in human clear cell renal cell carcinoma: in vitro effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 83
Nicotinamide N-methyltransferase: a key enzyme of pyridine metabolism and a target for human osteosarcoma treatment 83
Paraoxonase-2 (PON2) is upregulated in triple negative breast cancer and contributes to the tumor progression and chemoresistance 82
Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies 80
Validation of a nomogram for prognosis and stratification of patients with oral carcinoma 75
Catechol-O-methyltransferase, a potential biomarker for non-invasive diagnosis of human urothelial carcinoma 65
Role of nicotinamide N-methyltransferase in human osteosarcoma: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 65
NNMT expression in preeclampsia: Analyses on placental tissues and cell lines 52
Cisplatin as a Xenobiotic Agent: Molecular Mechanisms of Actions and Clinical Applications in Oncology 46
Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Enzyme for the Treatment of Osteosarcoma and Merkel Cell Carcinoma: Potential for the Development of a Targeted Therapeutic Strategy 40
Genetic and Epigenetic Biomarkers for the Early Oral Cancerization Risk in Periodontitis Patients 33
Short and Long Non-Coding RNAs in Renal Cell Carcinoma 21
Evaluation of nicotinamide N-methyltransferase enzyme expression in preeclampsia: analyses carried out in tissues and cell lines 18
Xenobiotic Sulforaphane in Head and Neck Cancer: Beyond the Nrf2 Pathway 5
Totale 9.847
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022359 17 59 40 4 0 19 12 59 9 14 45 81
2022/2023921 55 87 63 81 54 214 13 58 182 7 73 34
2023/2024771 98 16 57 66 105 113 10 18 15 95 36 142
2024/20251.552 155 74 78 38 72 32 134 69 249 160 192 299
2025/20265.369 427 293 793 429 564 329 929 416 449 427 168 145
2026/2027205 205 0 0 0 0 0 0 0 0 0 0 0
Totale 9.847